Pre-exposure prophylaxis (PrEP) is a cornerstone of America’s attempt to end HIV, but only about 25% of people with a PrEP indication are receiving it, explained Tam C. Phan, PharmD, AAHIVP, at the Academy of Managed Care Pharmacy (AMCP) Nexus 2022 meeting, in National Harbor, Md.
Most of the users of PrEP are men who have sex with men (MSM), especially white men, but some people, particularly Blacks and Latinx, cisgender and transgender women, and people who inject